Carlyle Group (CG)
(Delayed Data from NSDQ)
$41.06 USD
+0.48 (1.18%)
Updated May 3, 2024 04:00 PM ET
After-Market: $41.08 +0.02 (0.05%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
CG 41.06 +0.48(1.18%)
Will CG be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CG
After Plunging -13.6% in 4 Weeks, Here's Why the Trend Might Reverse for Carlyle (CG)
Carlyle (CG) Q1 Earnings Beat Estimates, Stock Falls 8.6%
CG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Carlyle Group (CG) is a Top Dividend Stock for Your Portfolio
Compared to Estimates, Carlyle (CG) Q1 Earnings: A Look at Key Metrics
Unlocking Q1 Potential of Carlyle (CG): Exploring Wall Street Estimates for Key Metrics
Other News for CG
Argentine banks rise, bitcoin miners fall in earnings-packed week: financials roundup
Private Equity Giants Choose Their Own Adventures
Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission
Analysts Offer Insights on Financial Companies: Kemper (KMPR) and Carlyle Group (CG)
Analysts Have Conflicting Sentiments on These Financial Companies: Carlyle Group (CG), NY Community (NYCB) and Peapack-Gladstone Financial (PGC)